K Langer

PEGylated human serum albumin (HSA) nanoparticles: preparation, characterization and quantification of the PEGylation extent

K. Langer, E Fahrländer, S Schelhaas, 2015, Nanotechnology.

Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases.

T. Wagner, S. Loitsch, K. Langer, 2004, Biochemical and biophysical research communications.

Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid.

H von Briesen, H. von Briesen, K. Langer, 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Optimization of the preparation process for human serum albumin (HSA) nanoparticles.

H von Briesen, V. Vogel, D. Schubert, 2003, International journal of pharmaceutics.

Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.

M. Michaelis, J. Cinatl, J. Kreuter, 2007, International journal of pharmaceutics.

Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: focus on cardio- and testicular toxicity.

J. Kreuter, K. Langer, S. Gelperina, 2007, International journal of pharmaceutics.